<DOC>
	<DOC>NCT02036645</DOC>
	<brief_summary>The purpose of this study is to assess the safety, drug levels and effects on the body of 1 or 3 injections of MEDI1814, in people with mild to moderate Alzhiemer's Disease or healthy elderly people.</brief_summary>
	<brief_title>SAD/MAD Study to Assess Safety, Tolerability, PK &amp; PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion Criteria Male and female (non child bearing potential) subjects Mildmoderate Alzheimer's Disease Exclusion Criteria History or evidence of significant autoimmune disease Presence of psychiatric disorder which would affect completion of the study Current serious or unstable clinically important illness</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>